# q04 rev 0 - blind solver B (raw, verbatim)

- Date: 2026-10-06. Fresh blind-solver agent (claude-opus-5-5, scope hook), given only the
  workspace root, the solver-2 packet path and the question. Copied verbatim from the task
  notification.
- tested_sha256: 4fda6f2ac451ec3f1115bbe1b100a2b2bf2662eba2f5ed198ffcb10decdc3a00

## Return

answer: **20.33%**

confidence: high

path:
1. **How the segment was redefined.** D11 (Q1 2026 release), note (1) at line 85, says Europe and Africa/Eurasia "and the skin health business (previously within the North America reportable operating segment) have been combined in a new Europe, Middle East &amp; Africa reportable operating segment." The new structure took effect "for the quarter ended March 31, 2026." So from 2026, North America no longer includes skin health.
2. **2025 figures under the new definition.** D10 (2026-03-17, "Segment Information (Recast)"). I checked these rows in the original file, docs/cl_ex991_2026-03-17.txt.
   - Full year 2025: "North America | $ 3,679 | $ 1,510 | $ 1,375 | $ 4 | $ 790" (net sales, cost of sales, SG&amp;A, other, operating profit).
   - Six months ended June 30, 2025: "North America | $ 1,823 | $ 737 | $ 700 | $ 3 | $ 384"
   - Three months ended September 30, 2025: "$ 922 … $ 199"
   - Nine months ended September 30, 2025: "$ 2,745 … $ 583"
3. **First half of 2026.** D12 (Q2 2026 release), Table 5. The six-month 2025 comparatives match D10.
   - Net sales: "North America(1) | $ 891 | $ 919 | $ 1,779 | $ 1,823"
   - Operating profit: "North America(1) | $ 192 | $ 187 | $ 333 | $ 384"
   - Note (1) says history was recast "to conform to the reporting structure effective for the quarter ended March 31, 2026."
   - Cross-check with D11 Table 4 (Q1 2026: $888 sales, $141 profit): 888 + 891 = 1,779 and 141 + 192 = 333.
4. **Second half of 2025 (July–December):**
   - Net sales: 3,679 − 1,823 = 1,856
   - Operating profit: 790 − 384 = 406
   - Cross-check by quarter: Q4 = 3,679 − 2,745 = 934 sales and 790 − 583 = 207 profit. Adding Q3 gives 922 + 934 = 1,856 and 199 + 207 = 406.
5. **Twelve months ended June 30, 2026:**
   - Net sales: 1,856 + 1,779 = $3,635M
   - Operating profit: 406 + 333 = $739M
   - Margin: 739 / 3,635 = 20.3301%, which rounds to **20.33%**. This is not near a rounding boundary.
   - Same result from FY2025 + H1 2026 − H1 2025: (790 + 333 − 384) / (3,679 + 1,779 − 1,823) = 739 / 3,635.

minimal_documents: D10 and D12. D10 is the only source of recast full-year or second-half 2025 data; D09 only has the old definition. D12 is the only source for Q2 2026 and the first half of 2026. D11 is optional: it explains the definition change and can stand in for the Q1 2026 part of D12's six-month figures, but D12 is still needed for Q2.

readings:
- **Mixing old and new definitions (rejected; contradicts the question).**
  - D09 old full year 2025: $4,045M sales, $784M profit.
  - D07 old first half 2025: $2,025M sales, $390M profit.
  - That gives a second half of 2,020 / 394. Adding the first half of 2026 (1,779 / 333) gives 727 / 3,799 = 19.14%.
- **Averaging the four quarterly margins (not the usual method).** The quarters are 21.58%, 22.16%, 15.88% and 21.55%, averaging 20.29%. The standard approach is total profit divided by total sales, which gives 20.33%.
- **Recomputing first-half 2025 profit from its components (rounding artifact).** 1,823 − 737 − 700 − 3 = 383 instead of the printed $384. That makes the second half 407, giving 740 / 3,635 = 20.36%. The printed $384 appears in both D10 and D12 and is the reported figure.

gaps:
- The inputs are rounded to $ millions, so the margin is computed from rounded figures.
- D01–D06 were not read in full. They cover 2019 and 2024 to early 2025, and I only searched them for "skin health", "recast" and "twelve months".
- D07–D09 were read only for North America rows and D09's segment table.
- The packet has no layout files or PDFs (all documents are plain text). I checked the key rows against the original docs/ files and found no extraction problems.
- I did not open question.txt.

contaminated: no. No answer, reasoning or source hint appeared in my input. I can't independently confirm how this session was launched.

Relevant files (under D:\Dev\Docket\tasks\aq-docket-trial-02\runs\q04-r0-v2-4fda6f2ac451ec3f1115bbe1b100a2b2bf2662eba2f5ed198ffcb10decdc3a00\solver-2\):
- text\D10.txt and docs\cl_ex991_2026-03-17.txt
- text\D12.txt and docs\cl_ex991_2026-07-31.txt
- text\D11.txt and docs\cl_ex991_2026-05-01.txt
